Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Novel systemic drugs under investigation for the treatment of psoriasis.

Gudjonsson JE, Johnston A, Ellis CN.

J Am Acad Dermatol. 2012 Jul;67(1):139-47. doi: 10.1016/j.jaad.2011.06.037. Epub 2012 Feb 2. Review.

PMID:
22305044
2.

Novel systemic drugs for psoriasis: mechanism of action for apremilast, a specific inhibitor of PDE4.

Schafer PH, Day RM.

J Am Acad Dermatol. 2013 Jun;68(6):1041-2. doi: 10.1016/j.jaad.2012.10.064. No abstract available.

PMID:
23680197
3.

New drugs in the treatment of psoriasis.

DiSepio D, Chandraratna RA.

Expert Opin Investig Drugs. 2000 Jan;9(1):79-93. Review.

PMID:
11060662
4.

[Role of new biological therapy in psoriasis treatment].

Cortijo Cascajares S, García Rodríguez MP, Campo Angora M, Serrano Garrote O, Herreros de Tejada A.

Farm Hosp. 2004 May-Jun;28(3):192-200. Review. Spanish.

5.

Current investigational drugs in psoriasis.

Ryan C, Abramson A, Patel M, Menter A.

Expert Opin Investig Drugs. 2012 Apr;21(4):473-87. doi: 10.1517/13543784.2012.669372. Epub 2012 Mar 8. Review.

PMID:
22400979
6.

Insight into the biomarkers as the novel anti-psoriatic drug discovery tool: a contemporary viewpoint.

Rahman M, Zaki Ahmad M, Kazmi I, Akhter S, Beg S, Gupta G, Afzal M, Saleem S, Ahmad I, Adil Shaharyar M, Jalees Ahmed F, Anwar F.

Curr Drug Discov Technol. 2012 Mar;9(1):48-62. Review.

PMID:
22023258
7.

Thiazolidinediones: potential as therapeutics for psoriasis and perhaps other hyperproliferative skin disease.

Varani J, Bhagavathula N, Ellis CN, Pershadsingh HA.

Expert Opin Investig Drugs. 2006 Nov;15(11):1453-68. Review.

PMID:
17040203
8.

Targeting tumor necrosis factor alpha. New drugs used to modulate inflammatory diseases.

LaDuca JR, Gaspari AA.

Dermatol Clin. 2001 Oct;19(4):617-35. Review.

PMID:
11705350
9.

Treatment of psoriasis. Part 2. Systemic therapies.

Lebwohl M, Ali S.

J Am Acad Dermatol. 2001 Nov;45(5):649-61; quiz 662-4. Review.

PMID:
11606913
10.

Psoriasis: what is new in nonbiologic systemic therapy in the era of biologics?

Kanwar AJ, Yadav S, Dogra S.

Indian J Dermatol Venereol Leprol. 2010 Nov-Dec;76(6):622-33. doi: 10.4103/0378-6323.72454. Review.

11.

Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?

Alwawi EA, Krulig E, Gordon KB.

Dermatol Ther. 2009 Sep-Oct;22(5):431-40. doi: 10.1111/j.1529-8019.2009.01259.x. Review.

PMID:
19845720
12.

Emerging drugs for moderate-to-severe psoriasis.

Magliocco MA.

Expert Opin Emerg Drugs. 2005 Feb;10(1):35-52. Review.

PMID:
15757402
13.

Oral tazarotene and oral pimecrolimus: novel oral therapies in development for psoriasis.

Singh F, Weinberg JM.

J Drugs Dermatol. 2004 Mar-Apr;3(2):141-3. Review.

PMID:
15098968
14.

Systemic therapy of psoriasis using methotrexate.

Smith KC.

Skin Therapy Lett. 2000;6(3):1-2; 5. Review.

PMID:
11176041
15.

Systemic combination treatment for psoriasis: a review.

Jensen P, Skov L, Zachariae C.

Acta Derm Venereol. 2010 Jul;90(4):341-9. doi: 10.2340/00015555-0905. Review.

16.

A pathogenetic approach to autoimmune skin disease therapy: psoriasis and biological drugs, unresolved issues, and future directions.

Ayroldi E, Bastianelli A, Cannarile L, Petrillo MG, Delfino DV, Fierabracci A.

Curr Pharm Des. 2011;17(29):3176-90. Review.

PMID:
21864268
17.

Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference.

Kalb RE, Strober B, Weinstein G, Lebwohl M.

J Am Acad Dermatol. 2009 May;60(5):824-37. doi: 10.1016/j.jaad.2008.11.906.

PMID:
19389524
18.

Psoriasis: hope for the future.

Sullivan-Whalen M, Gilleaudeau P.

Nurs Clin North Am. 2007 Sep;42(3):467-84, vii. Review.

PMID:
17825665
19.

Optimal management of severe plaque form of psoriasis.

Fairhurst DA, Ashcroft DM, Griffiths CE.

Am J Clin Dermatol. 2005;6(5):283-94. Review.

PMID:
16252928
20.

Classical to current approach for treatment of psoriasis: a review.

Rahman M, Alam K, Ahmad MZ, Gupta G, Afzal M, Akhter S, Kazmi I, Jyoti, Ahmad FJ, Anwar F.

Endocr Metab Immune Disord Drug Targets. 2012 Sep;12(3):287-302. Review.

PMID:
22463723

Supplemental Content

Support Center